Coronary angiography ACC-AHA characteristics of type A, B, and C coronary lesions: Difference between revisions
Gerald Chi- (talk | contribs) No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The [[American College of Cardiology]]/[[American Heart Association]] ([[ACC]]/[[AHA]]) Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures developed a classification scheme to characterize the complexity of [[Coronary artery stenosis|coronary stenosis]] and the probability of success of a [[percutaneous intervention]]. ACC/AHA lesion complexity system provides short-term prognostic information adjunctive to [[TIMI flow grade|TIMI flow grade (TFG)]] and [[TIMI myocardial perfusion grade|TIMI myocardial perfusion grade (TMPG)]]. | The [[American College of Cardiology]]/[[American Heart Association]] ([[ACC]]/[[AHA]]) Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures developed a classification scheme to characterize the complexity of [[Coronary artery stenosis|coronary stenosis]] and the probability of success of a [[percutaneous intervention]]. ACC/AHA lesion complexity system provides short-term prognostic information adjunctive to [[TIMI flow grade|TIMI flow grade (TFG)]] and [[TIMI myocardial perfusion grade|TIMI myocardial perfusion grade (TMPG)]]. | ||
==ACC/AHA Lesion-Specific Classification of the Primary Target Stenosis== | ==ACC/AHA Lesion-Specific Classification of the Primary Target Stenosis== | ||
The lesion-specific classification was proposed by the Subcommittee on Percutaneous Transluminal Coronary Angioplasty to estimate the likelihood of a successful [[Angioplasty#Coronary angioplasty|angioplastic procedure]] (defined as one in which a ≥20% change in luminal diameter is achieved, with the final diameter [[Coronary artery stenosis|stenosis]] <50% and without the occurrence of death, [[acute myocardial infarction]], or the need for emergency [[Coronary artery bypass surgery|bypass operation]]) as well as the likelihood of developing [[abrupt closure|abrupt vessel closure]].<ref>Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD,Peterson KL, Reeves TJ, Williams DO, Winters WL Jr, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988;78:486–502.</ref> | The lesion-specific classification was proposed by the Subcommittee on Percutaneous Transluminal Coronary Angioplasty to estimate the likelihood of a successful [[Angioplasty#Coronary angioplasty|angioplastic procedure]] (defined as one in which a ≥20% change in luminal diameter is achieved, with the final diameter [[Coronary artery stenosis|stenosis]] <50% and without the occurrence of death, [[acute myocardial infarction]], or the need for emergency [[Coronary artery bypass surgery|bypass operation]]) as well as the likelihood of developing [[abrupt closure|abrupt vessel closure]].<ref>Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD,Peterson KL, Reeves TJ, Williams DO, Winters WL Jr, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988;78:486–502.</ref> | ||
===Type A Lesions (High Success, >85%; Low Risk)=== | ===Type A Lesions (High Success, >85%; Low Risk)=== | ||
Type A lesions are associated with an anticipated success procedure rate of ≥85% and a low risk of [[abrupt closure]]. Type A lesions demonstrate all of the following characterisitics: | Type A lesions are associated with an anticipated success procedure rate of ≥85% and a low risk of [[abrupt closure]]. Type A lesions demonstrate all of the following characterisitics: | ||
* Discreteness (<10 mm in length) | * Discreteness (<10 mm in length) | ||
Line 23: | Line 26: | ||
===Type B Lesions (Moderate Success, 60 to 85%; Moderate Risk*)=== | ===Type B Lesions (Moderate Success, 60 to 85%; Moderate Risk*)=== | ||
Type B lesions are associated with an anticipated success procedure rate ranging from 60 to 85% or a moderate risk of abrupt closure, or both. Type B lesions include all lesions that are neither type A nor type C and are usually identified by, but not limited to, the following characterisitics: | Type B lesions are associated with an anticipated success procedure rate ranging from 60 to 85% or a moderate risk of abrupt closure, or both. Type B lesions include all lesions that are neither type A nor type C and are usually identified by, but not limited to, the following characterisitics: | ||
* Tubular shape (10 to 20 mm in length) | * Tubular shape (10 to 20 mm in length) | ||
Line 38: | Line 42: | ||
===Type C Lesions (Low Success, <60%; High Risk)=== | ===Type C Lesions (Low Success, <60%; High Risk)=== | ||
Type C lesions are associated with an anticipated success procedure rate of <60% or a high risk of abrupt closure, or both. Type C lesions demonstrate any of the following characterisitics: | Type C lesions are associated with an anticipated success procedure rate of <60% or a high risk of abrupt closure, or both. Type C lesions demonstrate any of the following characterisitics: | ||
* Diffuseness (>20 mm in length) | * Diffuseness (>20 mm in length) | ||
* Excessive tortuosity of proximal segments | * Excessive tortuosity of proximal segments | ||
Line 47: | Line 54: | ||
==Modified ACC/AHA Lesion-Specific Classification of the Primary Target Stenosis== | ==Modified ACC/AHA Lesion-Specific Classification of the Primary Target Stenosis== | ||
The standard ACC/AHA classification of the primary target stenosis is prospectively modified to subdivide type B stenoses into '''B1 (one adverse characteristic)''' and '''B2 (≥ two adverse characteristics)''' on the basis of previous studies suggesting the cumulative significance of mutiple adverse lesion characteristics. | |||
The standard ACC/AHA classification of the primary target stenosis is prospectively modified to subdivide type B stenoses into '''B1 (one adverse characteristic)''' and '''B2 (≥ two adverse characteristics)''' on the basis of previous studies suggesting the cumulative significance of mutiple adverse lesion characteristics.<ref>Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193–1202.</ref> | |||
==Clinical Significance== | ==Clinical Significance== | ||
* A greater ACC/AHA lesion complexity at 60 to 90 minutes after [[fibrinolytic]] administration was shown to be associated with poorer [[TIMI flow grade|epicardial flow]] and [[TIMI myocardial perfusion grade|myocardial perfusion]] as well as a higher risk of [[pulmonary edema]], [[shock]], and mortality within 30 days. However, increased lesion complexity was not associated with a higher risk of recurrent [[myocardial infarction]].<ref name="pmid15219518">{{cite journal| author=Gibson CM, Bigelow B, James D, Tepper MR, Murphy SA, Kirtane AJ et al.| title=Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction. |journal=Am J Cardiol | year= 2004 | volume= 94 | issue= 1 | pages= 108-11 | pmid=15219518 | doi=10.1016/j.amjcard.2004.03.038 | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15219518 }} </ref> | * A greater ACC/AHA lesion complexity at 60 to 90 minutes after [[fibrinolytic]] administration was shown to be associated with poorer [[TIMI flow grade|epicardial flow]] and [[TIMI myocardial perfusion grade|myocardial perfusion]] as well as a higher risk of [[pulmonary edema]], [[shock]], and mortality within 30 days. However, increased lesion complexity was not associated with a higher risk of recurrent [[myocardial infarction]].<ref name="pmid15219518">{{cite journal| author=Gibson CM, Bigelow B, James D, Tepper MR, Murphy SA, Kirtane AJ et al.| title=Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction. |journal=Am J Cardiol | year= 2004 | volume= 94 | issue= 1 | pages= 108-11 | pmid=15219518 | doi=10.1016/j.amjcard.2004.03.038 | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15219518 }} </ref> | ||
Line 55: | Line 64: | ||
==References== | ==References== | ||
{{ | |||
{{reflist|2}} | |||
{{Coronary Angiography}} | {{Coronary Angiography}} |
Revision as of 18:36, 6 April 2014
Coronary Angiography | |
General Principles | |
---|---|
Anatomy & Projection Angles | |
Normal Anatomy | |
Anatomic Variants | |
Projection Angles | |
Epicardial Flow & Myocardial Perfusion | |
Epicardial Flow | |
Myocardial Perfusion | |
Lesion Complexity | |
ACC/AHA Lesion-Specific Classification of the Primary Target Stenosis | |
Lesion Morphology | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]; Vanessa Cherniauskas, M.D. [3]
Overview
The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures developed a classification scheme to characterize the complexity of coronary stenosis and the probability of success of a percutaneous intervention. ACC/AHA lesion complexity system provides short-term prognostic information adjunctive to TIMI flow grade (TFG) and TIMI myocardial perfusion grade (TMPG).
ACC/AHA Lesion-Specific Classification of the Primary Target Stenosis
The lesion-specific classification was proposed by the Subcommittee on Percutaneous Transluminal Coronary Angioplasty to estimate the likelihood of a successful angioplastic procedure (defined as one in which a ≥20% change in luminal diameter is achieved, with the final diameter stenosis <50% and without the occurrence of death, acute myocardial infarction, or the need for emergency bypass operation) as well as the likelihood of developing abrupt vessel closure.[1]
Type A Lesions (High Success, >85%; Low Risk)
Type A lesions are associated with an anticipated success procedure rate of ≥85% and a low risk of abrupt closure. Type A lesions demonstrate all of the following characterisitics:
- Discreteness (<10 mm in length)
- Concentricity
- Ready accessibility
- Location in a nonangulated segment (<45°)
- Smoothness of contour
- Little or no calcification
- Absence of total occlusion
- Nonostial location
- Absence of major branch involvement
- Absence of thrombus
Type B Lesions (Moderate Success, 60 to 85%; Moderate Risk*)
Type B lesions are associated with an anticipated success procedure rate ranging from 60 to 85% or a moderate risk of abrupt closure, or both. Type B lesions include all lesions that are neither type A nor type C and are usually identified by, but not limited to, the following characterisitics:
- Tubular shape (10 to 20 mm in length)
- Eccentricity
- Accessibility influenced by moderate tortuosity of proximal segment
- Location in a moderately angulated segment (>45°, <90°)
- Irregularity of contour
- Moderate or severe calcification
- Presence of thrombus
- Ostial location
- Bifurcation lesions requiring double guide wires
- Total occlusions <3 months old
* Although the risk of abrupt vessel closure is moderate, in certain circumstances the likelihood of a major complication may be low as in dilation of total occlusions <3 months old or when abundant collateral channels supply the distal vessel.
Type C Lesions (Low Success, <60%; High Risk)
Type C lesions are associated with an anticipated success procedure rate of <60% or a high risk of abrupt closure, or both. Type C lesions demonstrate any of the following characterisitics:
- Diffuseness (>20 mm in length)
- Excessive tortuosity of proximal segments
- Location in an extremely angulated segment (>90°)
- Total occlusion >3 months old
- Inability to protect major side branches
- Degeneration of older vein grafts with friable lesions
Modified ACC/AHA Lesion-Specific Classification of the Primary Target Stenosis
The standard ACC/AHA classification of the primary target stenosis is prospectively modified to subdivide type B stenoses into B1 (one adverse characteristic) and B2 (≥ two adverse characteristics) on the basis of previous studies suggesting the cumulative significance of mutiple adverse lesion characteristics.[2]
Clinical Significance
- A greater ACC/AHA lesion complexity at 60 to 90 minutes after fibrinolytic administration was shown to be associated with poorer epicardial flow and myocardial perfusion as well as a higher risk of pulmonary edema, shock, and mortality within 30 days. However, increased lesion complexity was not associated with a higher risk of recurrent myocardial infarction.[3]
- Independent of left anterior descending coronary artery infarct location, TIMI grade 3 flow, age, performance of rescue or adjunctive PCI, pulse, and systolic blood pressure on admission, type C lesion complexity was associated with an increased short-term mortality rate at 30 days.[3]
References
- ↑ Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD,Peterson KL, Reeves TJ, Williams DO, Winters WL Jr, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988;78:486–502.
- ↑ Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193–1202.
- ↑ 3.0 3.1 Gibson CM, Bigelow B, James D, Tepper MR, Murphy SA, Kirtane AJ; et al. (2004). "Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction". Am J Cardiol. 94 (1): 108–11. doi:10.1016/j.amjcard.2004.03.038. PMID 15219518.